Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Pharma To Beef Up Transparency Policies In 2011 To Counter Public Concern - APEC Regulatory Conference

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Japanese pharma agreed to rollout updated in-house transparency guidelines in 2011 to strengthen compliance and improve the industry's public reputation
Advertisement

Related Content

Merck Tagged With Non-compliance In Japan For 3,600 Physicians' Unjustified Honoraria
Merck Tagged With Non-compliance In Japan For 3,600 Physicians' Unjustified Honoraria
RDPAC's Lobbying Efforts To Regulate China's Medical Representatives Likely To Pay Off This Year
Only One-fifth Of Japanese Medical Societies Have Conflict Of Interest Guidelines
Only One-fifth Of Japanese Medical Societies Have Conflict Of Interest Guidelines
Advertisement
UsernamePublicRestriction

Register

SC078139

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel